Endovascular therapy for M2 segment stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a minimally invasive procedure to remove a blood clot from a specific branch of a brain artery (the M2 segment) helps people recover from a stroke better than standard care alone. It is for people who have had a moderate to severe stroke within the past 24 hours and could not get clot-dissolving medicine or it didn't work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 84 years old.
- You must have had a recent stroke with a blockage in the M2 branch of the middle cerebral artery (a main brain artery).
- Before the stroke, you were able to do all your usual daily activities without help.
- Your stroke symptoms must be moderate to severe (NIHSS score of 8 or more).
- You must be able to start the procedure within 24 hours of the time you were last known to be well, and within 30 minutes of being assigned to this treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a special catheter system works to remove blood clots from smaller arteries in the brain after a stroke. It aims to see if this treatment helps people recover better.
This trial tests a minimally invasive procedure to remove blood clots from smaller arteries deep inside the brain. It may help people with moderate to severe stroke symptoms who can be treated within 24 hours of symptom onset.
This Phase 3 trial studies whether removing a clot using a catheter (endovascular thrombectomy) works better for certain types of acute ischemic stroke. It focuses on people with a blocked neck artery plus a blockage in the brain, and who can’t get or didn’t respond to IV clot-busting medicine.
This trial tests if a procedure to remove blood clots from brain arteries can help people who had a stroke more than 24 hours ago (up to 30 days). It aims to see if this treatment improves recovery for those with moderate to severe stroke symptoms.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests whether a minimally invasive procedure to remove a large clot from the basilar artery (a major artery in the back of the brain) can help people with severe stroke. It is for patients who have had a large stroke in this area within the past 24 hours.
Hear when a new Endovascular Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.